Role of donor and host cells in muscle‐derived stem cell‐mediated bone repair: differentiation vs. paracrine effects
暂无分享,去创建一个
J. Huard | J. Proto | J. Cummins | A. Ūsas | A. Lu | Xueqin Gao | Alexander Proctor | Chien‐Wen Chen | Jonathan D. Proto | A. Usas
[1] M. Ueda,et al. Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms. , 2014, Bone.
[2] B. Wang,et al. BMP2 is Superior to BMP4 for Promoting Human Muscle-Derived Stem Cell-Mediated Bone Regeneration in a Critical-Sized Calvarial Defect Model , 2013, Cell transplantation.
[3] J. Leor,et al. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. , 2013, Journal of the American College of Cardiology.
[4] D. Prockop,et al. Concise Review: Two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation , 2013, Stem cells.
[5] E. Shimizu,et al. Monocyte chemoattractant protein‐1 is a mediator of the anabolic action of parathyroid hormone on bone , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] Thomas E Sharp,et al. Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms , 2013, Circulation research.
[7] Amitava Das,et al. Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy: studies in a mouse model of multiple fractures. , 2013, Bone.
[8] B. Brown,et al. Quantitative multispectral imaging of Herovici's polychrome for the assessment of collagen content and tissue remodelling , 2013, Journal of tissue engineering and regenerative medicine.
[9] S. Hsiao,et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. , 2012, Stem cells and development.
[10] R. Cancedda,et al. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. , 2012, Biomaterials.
[11] D. Prockop,et al. Action at a Distance: Systemically Administered Adult Stem/Progenitor Cells (MSCs) Reduce Inflammatory Damage to the Cornea Without Engraftment and Primarily by Secretion of TNF‐α Stimulated Gene/Protein 6 , 2011, Stem cells.
[12] A. Tang,et al. Repair of Critical‐Sized Rat Calvarial Defects Using Genetically Engineered Bone Marrow‐Derived Mesenchymal Stem Cells Overexpressing Hypoxia‐Inducible Factor‐1α , 2011, Stem cells.
[13] Jing Hu,et al. Angiogenesis and osteogenesis enhanced by bFGF ex vivo gene therapy for bone tissue engineering in reconstruction of calvarial defects. , 2011, Journal of biomedical materials research. Part A.
[14] F. O'Brien,et al. Evaluation of early healing events around mesenchymal stem cell-seeded collagen–glycosaminoglycan scaffold. An experimental study in Wistar rats , 2011, Oral and Maxillofacial Surgery.
[15] M. Longaker,et al. Locally Applied Vascular Endothelial Growth Factor A Increases the Osteogenic Healing Capacity of Human Adipose‐Derived Stem Cells by Promoting Osteogenic and Endothelial Differentiation , 2011, Stem cells.
[16] Ralph Müller,et al. Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] R. Cancedda,et al. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. , 2010, Biomaterials.
[18] P. Sanberg,et al. Monocyte transplantation for neural and cardiovascular ischemia repair , 2009, Journal of cellular and molecular medicine.
[19] R. Guldberg,et al. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. , 2009, The American journal of pathology.
[20] R. Cancedda,et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. , 2009, Tissue engineering. Part A.
[21] J. Huard,et al. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. , 2009, Tissue engineering. Part A.
[22] B. Zheng,et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique , 2008, Nature Protocols.
[23] C. Kaps,et al. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. , 2008, European journal of cell biology.
[24] J. Kanczler,et al. Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.
[25] Gang Li,et al. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? , 2006, The Journal of bone and joint surgery. American volume.
[26] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Johnny Huard,et al. VEGF Improves, Whereas sFlt1 Inhibits, BMP2‐Induced Bone Formation and Bone Healing Through Modulation of Angiogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] J. Deng,et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Mastrogiacomo,et al. Bone and cartilage formation by skeletal muscle derived cells , 2005, Journal of cellular physiology.
[30] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[31] Freddie H. Fu,et al. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. , 2004, Bone.
[32] Marie-Christine Chaboissier,et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.
[33] Johnny Huard,et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.
[34] Johnny Huard,et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] Johnny Huard,et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. , 2002, Human gene therapy.
[36] A. M. Simon,et al. Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] E. Schwarz,et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. , 2002, The Journal of clinical investigation.
[38] Stephen A. Krawetz,et al. Bioinformatics Methods and Protocols , 1999 .
[39] B. Rollins,et al. Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.
[40] Robert V Farese,et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.
[41] D. Graves,et al. Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. , 1997, Bone.
[42] D. Prockop,et al. Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[43] M. Müller,et al. Angiogenesis: the role of PDGF-BB on adipose-tissue derived stem cells (ASCs). , 2011, Clinical hemorheology and microcirculation.
[44] R. Cancedda,et al. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. , 2010, Biomaterials.
[45] Krisztián Németh,et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.
[46] H. Kagami,et al. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit. , 2005, Cytotherapy.
[47] J. Huard,et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. , 2002, The Journal of bone and joint surgery. British volume.